Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Definitive radiotherapy vs. postoperative radiotherapy for lower gingival carcinomas of the mandible : A single-center report about outcome and toxicity.

Lang K, Akbaba S, Held T, Kargus S, Horn D, Bougatf N, Bernhardt D, Freier K, Rieken S, Debus J, Adeberg S.

Strahlenther Onkol. 2019 Jul 2. doi: 10.1007/s00066-019-01484-z. [Epub ahead of print]

PMID:
31267170
2.

Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial.

Hauswald H, Bernhardt D, Krug D, Katayama S, Habl G, Lorenzo Bermejo J, Debus J, Sterzing F.

Cancer Manag Res. 2019 May 24;11:4669-4676. doi: 10.2147/CMAR.S204729. eCollection 2019.

3.

Clinical Management of Blood⁻Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer.

Held T, Akbaba S, Lang K, Harrabi S, Bernhardt D, Freudlsperger C, Kargus S, Plinkert P, Rieken S, Herfarth K, Debus J, Adeberg S.

Cancers (Basel). 2019 Mar 19;11(3). pii: E383. doi: 10.3390/cancers11030383.

4.

Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases-Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept.

El Shafie RA, Tonndorf-Martini E, Schmitt D, Weber D, Celik A, Dresel T, Bernhardt D, Lang K, Hoegen P, Adeberg S, Paul A, Debus J, Rieken S.

Cancers (Basel). 2019 Mar 1;11(3). pii: E294. doi: 10.3390/cancers11030294.

5.

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Sterzing F, Hörner-Rieber J, Löw S, Herfarth K, Debus J, Rieken S, Bernhardt D.

Cancer Manag Res. 2019 Jan 17;11:789-801. doi: 10.2147/CMAR.S182154. eCollection 2019.

6.

Palliative Radiotherapy for Leptomeningeal Carcinomatosis-Analysis of Outcome, Prognostic Factors, and Symptom Response.

El Shafie RA, Böhm K, Weber D, Lang K, Schlaich F, Adeberg S, Paul A, Haefner MF, Katayama S, Hörner-Rieber J, Hoegen P, Löw S, Debus J, Rieken S, Bernhardt D.

Front Oncol. 2019 Jan 8;8:641. doi: 10.3389/fonc.2018.00641. eCollection 2018.

7.

Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy.

Bernhardt D, Aufderstrasse S, König L, Adeberg S, Bozorgmehr F, Christopoulos P, Shafie RAE, Hörner-Rieber J, Kappes J, Thomas M, Herth F, Steins M, Debus J, Rieken S.

Cancer Manag Res. 2018 Nov 30;10:6563-6569. doi: 10.2147/CMAR.S180990. eCollection 2018.

8.

Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity.

Lang K, Baur M, Akbaba S, Held T, Kargus S, Bougatf N, Bernhardt D, Freier K, Plinkert PK, Rieken S, Debus J, Adeberg S.

Cancers (Basel). 2018 Dec 4;10(12). pii: E488. doi: 10.3390/cancers10120488.

9.

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Liermann J, Syed M, Held T, Bernhardt D, Plinkert P, Jungk C, Unterberg A, Rieken S, Debus J, Herfarth K, Adeberg S.

Cancers (Basel). 2018 Nov 20;10(11). pii: E457. doi: 10.3390/cancers10110457.

10.

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Adeberg S, Harrabi SB, Bougatf N, Verma V, Windisch P, Bernhardt D, Combs SE, Herfarth K, Debus J, Rieken S.

Cancers (Basel). 2018 Oct 26;10(11). pii: E401. doi: 10.3390/cancers10110401.

11.

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy.

Syed M, Liermann J, Verma V, Bernhardt D, Bougatf N, Paul A, Rieken S, Debus J, Adeberg S.

Cancer Manag Res. 2018 Oct 4;10:4229-4235. doi: 10.2147/CMAR.S165956. eCollection 2018.

12.

High-resolution FLAIR MRI at 7 Tesla for treatment planning in glioblastoma patients.

Regnery S, Knowles BR, Paech D, Behl N, Meissner JE, Windisch P, Ben Harrabi S, Bernhardt D, Schlemmer HP, Ladd ME, Rieken S, Debus J, Adeberg S.

Radiother Oncol. 2019 Jan;130:180-184. doi: 10.1016/j.radonc.2018.08.002. Epub 2018 Aug 31.

13.

Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial.

Bernhardt D, Hommertgen A, Schmitt D, El Shafie R, Paul A, König L, Mair-Walther J, Krisam J, Klose C, Welzel T, Hörner-Rieber J, Kappes J, Thomas M, Heußel CP, Steins M, Kieser M, Debus J, Rieken S.

Trials. 2018 Jul 16;19(1):388. doi: 10.1186/s13063-018-2745-x.

14.

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series.

Bernhardt D, Sterzing F, Adeberg S, Herfarth K, Katayama S, Foerster R, Hoerner-Rieber J, König L, Debus J, Rieken S.

Cancer Manag Res. 2018 Mar 26;10:583-588. doi: 10.2147/CMAR.S148395. eCollection 2018.

15.

Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)-A Single-Center Prospective Randomized Trial.

El Shafie RA, Paul A, Bernhardt D, Lang K, Welzel T, Sprave T, Hommertgen A, Krisam J, Schmitt D, Klüter S, Schubert K, Klose C, Kieser M, Debus J, Rieken S.

Neurosurgery. 2019 Jan 1;84(1):253-260. doi: 10.1093/neuros/nyy026.

PMID:
29554321
16.

Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.

El Shafie RA, Paul A, Bernhardt D, Hauswald H, Welzel T, Sprave T, Hommertgen A, Krisam J, Schmitt D, Klüter S, Schubert K, Klose C, Kieser M, Debus J, Rieken S.

Neurosurgery. 2018 Sep 1;83(3):566-573. doi: 10.1093/neuros/nyy021.

PMID:
29528419
17.

Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.

König L, Hörner-Rieber J, Bernhardt D, Hommertgen A, Rieken S, Debus J, Herfarth K.

Strahlenther Onkol. 2018 May;194(5):454-461. doi: 10.1007/s00066-018-1277-3. Epub 2018 Feb 15.

PMID:
29450588
18.

Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.

Bernhardt D, König L, Aufderstrasse S, Krisam J, Hoerner-Rieber J, Adeberg S, Bozorgmehr F, El Shafie R, Lang K, Kappes J, Thomas M, Herth F, Heußel CP, Warth A, Marcrom S, Debus J, Steins M, Rieken S.

Clin Lung Cancer. 2018 Jul;19(4):340-345. doi: 10.1016/j.cllc.2017.12.004. Epub 2017 Dec 15.

PMID:
29373273
19.

Metformin Enhanced in Vitro Radiosensitivity Associates with G2/M Cell Cycle Arrest and Elevated Adenosine-5'-monophosphate-activated Protein Kinase Levels in Glioblastoma.

Adeberg S, Bernhardt D, Harrabi SB, Nicolay NH, Hörner-Rieber J, König L, Repka M, Mohr A, Abdollahi A, Weber KJ, Debus J, Rieken S.

Radiol Oncol. 2017 Nov 1;51(4):431-437. doi: 10.1515/raon-2017-0042. eCollection 2017 Dec.

20.

Treatment of meningioma and glioma with protons and carbon ions.

Adeberg S, Harrabi SB, Verma V, Bernhardt D, Grau N, Debus J, Rieken S.

Radiat Oncol. 2017 Dec 1;12(1):193. doi: 10.1186/s13014-017-0924-7. Review.

Supplemental Content

Loading ...
Support Center